Skip to main content

Table 5 Comparison of the dosimetry outcomes

From: A head-to-head comparison between two commercial software packages for hybrid dosimetry after peptide receptor radionuclide therapy

   KidneysRed marrowTumour lesions
Mono-exponentialAbsolute difference (Gy/GBq)Bias0.026 ± 0.120.047 ± 0.019−0.37 ± 0.86
95% LOA−0.37 − 0.420.01 − 0.08−2.05 − 1.31
Relative difference (%)Bias−0.53 ± 29.03116 ± 38.5−8.36 ± 19.19
95% LOA−57.4 − 56.441.0 − 192−46.0 − 26.3
Spearman correlation0.903−0.7010.963
ICC - agreement0.708Negative0.804
Bi-exponentialAbsolute difference (Gy/GBq)Bias−0.042 ± 0.160.088 ± 0.0150.39 ± 0.92
95% LOA−0.348 − 0.2650.057 − 0.118−1.41 − 2.19
Relative difference (%)Bias−5.63 ± 32.07169 ± 12.8−9.52 ± 26.66
95% LOA−68.5 − 57.2144 − 194−42.7 − 61.8
Spearman correlation0.491−0.4180.907
ICC - agreement0.537Negative0.921
  1. LOA limits of agreement, ICC intraclass correlation coefficient